Stem Cell Caution
By Richard Hayes,
Tom Paine
| 05. 24. 2006
Support for stem cell research has become a cause célèbre among Democrats. Last year New Jersey Senator Jon Corzine made it a big part of his successful campaign for Governor. This year New York Attorney General Elliott Spitzer is proposing a $1 billion stem cell bond issue as part of his own gubernatorial campaign. In Missouri Democrat Claire McCaskill is spotlighting stem cell research in her effort to unseat Republican Senator Jim Talent. And this week marks the one year anniversary of the passage of Castle-DeGette, the House bill that expands federal funding for stem cell research. Senate Democrats are rallying to push for a vote as soon as possible on the Senate version of this bill.
I'm a life-long liberal Democrat, pro-choice on abortion and a supporter of innovative medical research. I believe that stem cell research holds promise, and that the Bush administration's policies are unnecessarily restrictive. Now stem cells appear to be giving Democrats a potent vote-getting wedge issue.
Why am I worried about this?
I'm worried because in their over-the-top enthusiasm for stem cell and cloning...
Related Articles
By Alondra Nelson, Science | 01.15.2026
One of the most interventionist approaches to technology governance in the United States in a generation has cloaked itself in the language of deregulation. In early December 2025, President Donald Trump took to Truth Social to announce a forthcoming “One...
By Evelina Johansson Wilén, Jacobin | 01.18.2026
In her book The Argonauts, Maggie Nelson describes pregnancy as an experience marked by a peculiar duality. On the one hand, it is deeply transformative, bodily alien, sometimes almost incomprehensible to the person undergoing it. On the other hand...
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...